000919 Jinling Pharmaceutical
- 6.53
- +0.09+1.40%
Jinling Pharmaceutical News
Jinling Pharmaceutical: Announcement of Jinling Pharmaceutical Co., Ltd. on adjusting the repurchase price of the 2021 Restricted Stock Incentive Plan and the repurchase and cancellation of some restricted stocks that have been granted but the sales restrictions have not yet been lifted
Jinling Pharmaceutical: Legal Opinion of Jiangsu Taihe Law Firm on Jinling Pharmaceutical Co., Ltd.\'s 2021 Restricted Stock Incentive Plan Repurchase Price Adjustment and Repurchase Cancellation of Some Restricted Shares
Jinling Pharmaceutical: Jinling Pharmaceutical Co., Ltd. 2023 Equity Distribution Implementation Notice
Jinling Pharmaceutical: CITIC Securities Co., Ltd. listing sponsorship for Jinling Pharmaceutical Co., Ltd. to issue A-shares to specific targets in 2023
Jinling Pharmaceutical: Announcement on the issuance of A-shares by Jinling Pharmaceutical Co., Ltd. to specific targets in 2023
Jinling Pharmaceutical: Announcement of Jinling Pharmaceutical Co., Ltd. on passively diluting the shareholders' shareholding ratio by more than 1%
Jinling Pharmaceutical: An indicative announcement by Jinling Pharmaceutical Co., Ltd. on the disclosure of stock listing notices issued to specific targets
Jinling Pharmaceutical: Capital Verification Report on the Issuance of A-shares by Jinling Pharmaceutical Co., Ltd. to specific targets to raise capital
Jinling Pharmaceutical: Report on the issuance of A-shares to specific targets by Jinling Pharmaceutical Co., Ltd. in 2023
Jinling Pharmaceutical: An indicative announcement by Jinling Pharmaceutical Co., Ltd. on the disclosure of a report on the issuance of shares to specific targets
Jinling Pharmaceutical: Report of CITIC Securities Co., Ltd. on the issuance process of Jinling Pharmaceutical Co., Ltd.'s issuance process of A-shares to specific targets in 2023 and compliance with subscription targets
Jinling Pharmaceutical: Legal Opinion of Jiangsu Taihe Law Firm on the issuance process of Jinling Pharmaceutical Co., Ltd. to issue A shares to specific targets in 2023 and compliance with subscription targets
Jinling Pharmaceutical: CITIC Securities Co., Ltd.'s inspection opinions on extending the validity period of the resolution of Jinling Pharmaceutical Co., Ltd.'s shareholders' meeting in 2023 to issue A shares to specific targets and the validity period of
Jinling Pharmaceutical: Written review opinion of the board of supervisors of Jinling Pharmaceutical Co., Ltd. on matters relating to the company's adjustment to issue A-shares to specific targets in 2023
Jinling Pharmaceutical: Prospectus for the issuance of A-shares to specific targets by Jinling Pharmaceutical Co., Ltd. in 2023 (registration draft)
Jinling Pharmaceutical: Announcement of Jinling Pharmaceutical Co., Ltd. on the application for issuing shares to specific targets to obtain registration approval from the China Securities Regulatory Commission
Jinling Pharmaceutical: CITIC Securities Co., Ltd.\'s issuance sponsorship letter for Jinling Pharmaceutical Co., Ltd. to issue A-shares to specific targets in 2023
Jinling Pharmaceutical: CITIC Securities Co., Ltd.\'s listing sponsorship letter for Jinling Pharmaceutical Co., Ltd. to issue A-shares to specific targets in 2023
Jinling Pharmaceutical: Jinling Pharmaceutical Co., Ltd. issues A-share prospectus for specific targets in 2023 (registration draft)
Jinling Pharmaceutical: CITIC Securities Co., Ltd.\'s issuance sponsorship letter for Jinling Pharmaceutical Co., Ltd. to issue A-shares to specific targets in 2023
Analysis
Price Target
No Data
No Data